Defibrotide Free Acid: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Defibrotide Free Acid. Educational only — not medical advice.
Labeled uses
DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).
Source: FDA labeling via NIH DailyMed (set 2c3db989…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.